104 related articles for article (PubMed ID: 20731571)
1. Empirical enterococcal coverage for complicated intra-abdominal infection.
Tarchini G
Clin Infect Dis; 2010 Sep; 51(6):757-8; author reply 758-9. PubMed ID: 20731571
[No Abstract] [Full Text] [Related]
2. [Role of enterococci in intra-abdominal infection and possible implications in the therapeutic choice].
García-Rodríguez JA; García Sánchez JE; García Sánchez E
Rev Clin Esp; 1995 Oct; 195 Suppl 4():28-34. PubMed ID: 9441313
[No Abstract] [Full Text] [Related]
3. Treatment recommendations for patients from the community: concerns regarding the new guidelines for treatment of intra-abdominal infection.
Piacenti F
Clin Infect Dis; 2010 Sep; 51(6):755-7; author reply 758-9. PubMed ID: 20731570
[No Abstract] [Full Text] [Related]
4. Is combination systemic therapy superior to monotherapy for enterococcal prosthetic joint infection?
Nsutebu EF; Hobson R
Clin Infect Dis; 2009 Feb; 48(4):495; author reply 495-6. PubMed ID: 19586378
[No Abstract] [Full Text] [Related]
5. Trends in treatment of antimicrobial-resistant enterococcal infections.
Xia L; Murray BE
Curr Clin Top Infect Dis; 2000; 20():92-112. PubMed ID: 10943520
[No Abstract] [Full Text] [Related]
6. Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections.
Fisher L; North D
Int J Antimicrob Agents; 2009 May; 33(5):493-4. PubMed ID: 19153034
[No Abstract] [Full Text] [Related]
7. Vancomycin-resistant enterococcal infections.
Murray BE
N Engl J Med; 2000 Mar; 342(10):710-21. PubMed ID: 10706902
[No Abstract] [Full Text] [Related]
8. The implications of enterococci for the intensive care unit.
Chatterjee I; Iredell JR; Woods M; Lipman J
Crit Care Resusc; 2007 Mar; 9(1):69-75. PubMed ID: 17352670
[TBL] [Abstract][Full Text] [Related]
9. Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence?
Cai T; Mazzoli S; Malossini G; Bartoletti R
J Antimicrob Chemother; 2011 May; 66(5):1195-6; author reply 1196-7. PubMed ID: 21186192
[No Abstract] [Full Text] [Related]
10. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children.
Lin WJ; Lo WT; Chu CC; Chu ML; Wang CC
J Microbiol Immunol Infect; 2006 Jun; 39(3):249-54. PubMed ID: 16783457
[TBL] [Abstract][Full Text] [Related]
11. [Research advances in vancomycin-resistant enterococcal infections].
Zhang SF
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):230-2. PubMed ID: 12911021
[No Abstract] [Full Text] [Related]
12. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
13. [Reduction of antibiotic resistance of Enterococcus faecalis in infections of the genitourinary tract].
Manfredi R; Nanetti A; Valentini R; Morelli S; Ferri M; Calza L; Chiodo F
Recenti Prog Med; 2002 Dec; 93(12):681-2. PubMed ID: 12587606
[TBL] [Abstract][Full Text] [Related]
14. [Enterococcal resistance to glycopeptide antibiotics].
Cercendado Mansilla E
Rev Clin Esp; 1995 Oct; 195 Suppl 4():22-7. PubMed ID: 9441312
[No Abstract] [Full Text] [Related]
15. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.
Solomkin JS; Mazuski JE; Baron EJ; Sawyer RG; Nathens AB; DiPiro JT; Buchman T; Dellinger EP; Jernigan J; Gorbach S; Chow AW; Bartlett J;
Clin Infect Dis; 2003 Oct; 37(8):997-1005. PubMed ID: 14523762
[No Abstract] [Full Text] [Related]
16. [Intra-abdominal infection: key facts].
Garau J; García Sánchez JE
Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():1. PubMed ID: 21130923
[No Abstract] [Full Text] [Related]
17. Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.
Goldstein EJ; Snydman DR
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii29-36. PubMed ID: 15150181
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study.
Anderson DJ; Murdoch DR; Sexton DJ; Reller LB; Stout JE; Cabell CH; Corey GR
Infection; 2004 Apr; 32(2):72-7. PubMed ID: 15057570
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
Leclercq R
Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
[TBL] [Abstract][Full Text] [Related]
20. Microbiology and drug resistance mechanisms of fully resistant pathogens.
Walsh FM; Amyes SG
Curr Opin Microbiol; 2004 Oct; 7(5):439-44. PubMed ID: 15451497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
